Literature DB >> 8910519

Isolation of a NCK-associated kinase, PRK2, an SH3-binding protein and potential effector of Rho protein signaling.

L A Quilliam1, Q T Lambert, L A Mickelson-Young, J K Westwick, A B Sparks, B K Kay, N A Jenkins, D J Gilbert, N G Copeland, C J Der.   

Abstract

The NCK adapter protein is comprised of three consecutive Src homology 3 (SH3) protein-protein interaction domains and a C-terminal SH2 domain. Although the association of NCK with activated receptor protein-tyrosine kinases, via its SH2 domain, implicates NCK as a mediator of growth factor-induced signal transduction, little is known about the pathway(s) downstream of NCK recruitment. To identify potential downstream effectors of NCK we screened a bacterial expression library to isolate proteins that bind its SH3 domains. Two molecules were isolated, the Wiskott-Aldrich syndrome protein (WASP, a putative CDC42 effector) and a serine/threonine protein kinase (PRK2, closely related to the putative Rho effector PKN). Using interspecific backcross analysis the Prk2 gene was mapped to mouse chromosome 3. Unlike WASP, which bound the SH3 domains of several signaling proteins, PRK2 specifically bound to the middle SH3 domain of NCK and (weakly) that of phospholipase Cgamma. PRK2 also specifically bound to Rho in a GTP-dependent manner and cooperated with Rho family proteins to induce transcriptional activation via the serum response factor. These data suggest that PRK2 may coordinately mediate signal transduction from activated receptor protein-tyrosine kinases and Rho and that NCK may function as an adapter to connect receptor-mediated events to Rho protein signaling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910519     DOI: 10.1074/jbc.271.46.28772

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

Review 2.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 3.  Actin-based motility of intracellular microbial pathogens.

Authors:  M B Goldberg
Journal:  Microbiol Mol Biol Rev       Date:  2001-12       Impact factor: 11.056

4.  Physical and functional interactions of Galphaq with Rho and its exchange factors.

Authors:  S A Sagi; T M Seasholtz; M Kobiashvili; B A Wilson; D Toksoz; J H Brown
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

5.  The Rho target PRK2 regulates apical junction formation in human bronchial epithelial cells.

Authors:  Sean W Wallace; Ana Magalhaes; Alan Hall
Journal:  Mol Cell Biol       Date:  2010-10-25       Impact factor: 4.272

6.  Multiple cytoskeletal pathways and PI3K signaling mediate CDC-42-induced neuronal protrusion in C. elegans.

Authors:  Jamie K Alan; Eric C Struckhoff; Erik A Lundquist
Journal:  Small GTPases       Date:  2013-10-22

7.  Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins.

Authors:  D D Schlaepfer; M A Broome; T Hunter
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

8.  Domain requirements for the Dock adapter protein in growth- cone signaling.

Authors:  Y Rao; S L Zipursky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

9.  Protein kinase N2 regulates AMP kinase signaling and insulin responsiveness of glucose metabolism in skeletal muscle.

Authors:  Maxwell A Ruby; Isabelle Riedl; Julie Massart; Marcus Åhlin; Juleen R Zierath
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-07-18       Impact factor: 4.310

10.  Human enhancer of invasion-cluster, a coiled-coil protein required for passage through mitosis.

Authors:  Margret B Einarson; Edna Cukierman; Duane A Compton; Erica A Golemis
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.